Home/Smart Money/Octagon Capital Advisors LP
§ 13F · FUND PROFILE

Octagon Capital Advisors LP.

AUM · $1.1B (13F)Positions · 27Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$67M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1DNTHDIANTHUS THERAPEUTICS INC1.84M$180M16.1%−5%
2DFTXDEFINIUM THERAPEUTICS INC2.95M$139M12.5%+21%
3ABVXABIVAX SA993K$132M11.9%+47%
4COGTCOGENT BIOSCIENCES INC2.35M$91M8.2%±0%
5ALMSALUMIS INC2.83M$80M7.2%±0%
6AVBPARRIVENT BIOPHARMA INC1.97M$68M6.2%±0%
7TSHATAYSHA GENE THERAPIES INC9.69M$66M5.9%+9%
8BIOABIOAGE LABS INC1.75M$43M3.9%±0%
9MIRMMIRUM PHARMACEUTICALS INC339K$40M3.6%±0%
10KYMRKYMERA THERAPEUTICS INC310K$36M3.2%−27%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE OCTAGON SIGNAL

AC read

Octagon Capital Advisors LP is a Other fund managing $1.1 billion in assets. The fund runs a focused portfolio of just 27 positions.

Read the full dossier →